CME ACCREDITATION AND DESIGNATION
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians should claim only the credit commensurate with the extent of their participation in the activity. Documentation of awarded credit is provided for participants in exchange for completed activity evaluations.
OVERVIEW
The field of interventional cardiology has made great strides in developing innovative treatments that have changed the lives of heart patients around the world. Transcatheter aortic valve replacement (TAVR) is a less invasive alternative to traditional valve replacement surgery. Currently, TAVR is being used successfully in high-risk patients. This program will move beyond high-risk patients and explore the new boundaries of transcatheter therapy. Participants learn from discussions about valve durability, treating bicuspid patients, and advanced valve-in-valve concepts. Expert panelists also discuss recent clinical trial data.
AGENDA
Welcome and Introductions: TAVR in Low-Risk Patients – Critical Review of the Clinical Evidence
Michael J. Reardon
The Optimal TAVR Low-Risk Patient: Understanding Treatment Decision-making in 2019
Kendra J. Grubb
What Is Important to Low-Risk Patients? (Mortality/Stroke, Qualify of Life, Hemodynamics, and more)
Howard C. Herrmann
TAVR in Bicuspid Patients: Evidence and Case Examples
Didier Tchetche
TAVR in Low-Risk Patients
Hemal Gada
LEARNING OBJECTIVES
By the end of this program, participants should be able to:
• Explain valve durability/thrombosis and hemodynamics
• Discuss recent clinical trial data
• Describe considerations for treating bicuspid patients
• Express important considerations of TAVR in the low-risk patient
TARGET AUDIENCE
This educational activity is designed for interventional cardiologists, clinical cardiologists, and other healthcare professionals involved
in the management of patients with valvular heart disease.
ACTIVITY EVALUATION
Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.
DISCLOSURE STATEMENT
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the course directors of this activity.
All Planners (Directors, Co-Directors and Chairs) and Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Anyone in noncompliance with this policy is not permitted to participate in this activity.
FACULTY DISCLOSURE SUMMARY
KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E/S/O) Equity/Stock(s)/Options (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit
Hemal Gada: (C/H/S) Medtronic, Abbott Vascular, Boston Scientific Corporation, Bard Medical
Kendra J. Grubb: (C/H/S) Edwards Lifesciences, Boston Scientific Corporation, Medtronic
Howard C. Herrmann: (G/R) Abbott Vascular, Ancora Heart, Boston Scientific Corporation, (G/R) (C/H/S) Edwards Lifesciences, Medtronic
Michael J. Reardon: (C/H/S) Medtronic
Didier Tchetche: Nothing to Disclose
Content Reviewer(s):
Gary S. Mintz, MD – Nothing to disclose
Joe Heard, MHA - Nothing to disclose
Colleen Whelan - Nothing to disclose
ACTIVITY SPONSORSHIP AND SUPPORT
This program is sponsored by the Cardiovascular Research Foundation and supported through an unrestricted grant from Medtronic. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience. This program was developed without influence from commercial supporters.
HOW TO RECEIVE CME CREDIT
To obtain CME credit for this activity, participants must review all CME information, view all presentations in their entirety, and complete the Activity Evaluation Form. If you have any questions, please contact Joe Heard at jheard@crf.org .